Swedish Orphan Biovitrum AB (publ) (BIOVF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
As of 01:26PM EDT. Market open.
| Previous Close | 22.87 |
| Open | 23.74 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 22.87 - 22.87 |
| 52 Week Range | 18.35 - 27.79 |
| Volume | |
| Avg. Volume | 88 |
| Market Cap | 8.053B |
| Beta (5Y Monthly) | 0.26 |
| PE Ratio (TTM) | 34.13 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- PR Newswire
Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)
The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby summoned to the Annual General Meeting (the "Meeting"), to be held on Tuesday, 14 May 2024 at 15.00 at IVA Konferenscenter, Grev Turegatan 16, Stockholm, Sweden.
- PR Newswire
Sobi publishes Annual and sustainability report for 2023
Swedish Orphan Biovitrum AB (publ) (Sobi®) today published its Annual and sustainability report for 2023. Inspired by caring and powered by science, the integrated report summarises business and strategy, financial performance, and work on sustainability.
- PR Newswire
Sobi publishes Q4 2023 report: Strong revenue performance and growth into 2024
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the fourth quarter 2023.
© 2024 Yahoo. All rights reserved.